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Manymolecular epidemiology studies focusing on high prevalent diseases, such as meta-
bolic disorders and cancer, investigate metabolic and hormonal markers. In general, sam-
pling for these markers can occur at any time-point during the day or after an overnight fast.
However, environmental factors, such as light exposure and food intake might affect the lev-
els of these markers, since they provide input for the internal time-keeping system. When
diurnal variation is larger than the inter-individual variation, time of day should be taken into
account. Importantly, heterogeneity in diurnal variation and disturbance of circadian rhythms
among a study population might increasingly occur as a result of our increasing 24/7 econ-
omy and related variation in exposure to environmental factors (such as light and food).
Aim
The aim of the present study was to determine whether a set of often used biomarkers
shows diurnal variation in a setting resembling large molecular epidemiology studies, i.e.,
non-fasted and limited control possibilities for other environmental influences.
Results
We show that markers for which diurnal variation is not an issue are adrenocorticotropic hor-
mone, follicle stimulating hormone, estradiol and high-density lipoprotein. For all other
tested markers diurnal variation was observed in at least one gender (cholesterol, cortisol,
dehydroepiandrosterone sulfate, free fatty acids, low-density lipoprotein, luteinizing hor-
mone, prolactin, progesterone, testosterone, triglycerides, total triiodothyronine and thyroid-
stimulating hormone) or could not reliably be detected (human growth hormone).
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Discussion
Thus, studies investigating these markers should take diurnal variation into account, for
which we provide some options. Furthermore, our study indicates the need for investigating
diurnal variation (in literature or experimentally) before setting up studies measuring mark-
ers in routine and controlled settings, especially since time-of-day likely matters for many
more markers than the ones investigated in the present study.
Introduction
Many molecular epidemiology studies focusing on high prevalent diseases, such as metabolic
disorders and cancer [1, 2], make use of metabolic and hormonal markers (for examples see
references [3, 4]. Metabolic markers might serve as important (early) indicators for metabolic
disorders, including cardiovascular diseases and type 2 diabetes, and hormonal disbalance is
often studied in large epidemiological settings since these are associated with high incidence
cancers, such as breast cancer [5–7]. In general, for these markers sampling can occur at any
time-point during the day or after an overnight fast. However, environmental factors, such as
light exposure and food intake might affect the levels of these markers, since they provide input
for the internal time-keeping system [8–11]. Several markers are well known for their diurnal
variation, for example cortisol and melatonin [12]. Importantly, heterogeneity in diurnal varia-
tion and disturbance of circadian rhythms among a study population might increasingly occur
as a result of our increasing 24/7 economy and related variation in exposure to environmental
factors (such as light and food). For example, previous studies have indicated that there are
substantial changes in the blood transcriptome after experiencing insufficient or mistimed
sleep [13, 14]. This might render accurate determination of markers in molecular epidemiology
studies challenging. When the diurnal variation is larger than the inter-individual variation,
time of day should be taken into account in molecular epidemiology studies. In this study, we
determine whether a set of biomarkers relevant for metabolic disorders and hormone-associ-
ated cancers, consisting of endocrine and sex hormones and lipids, shows diurnal variation.
The diurnal variation of various blood markers has previously been studied in different set-
tings, ranging from a relatively uncontrolled routine setting to very tightly controlled labora-
tory settings. Most information on diurnal variation is derived from these controlled
laboratory studies in which factors influencing diurnal variation (such as food intake and/or
sleep/wake cycle) are controlled (for example see references [15–21]). Due to the large-scale set
up of some molecular epidemiology studies, the possibility for standardization of sample col-
lection to time of day and food consumption is limited. Therefore, most molecular epidemiol-
ogy studies collect blood samples to study biomarkers for adverse health outcomes without
standardization for time-point, food intake or sleep.
The aim of the present study was to investigate diurnal variation of a set of markers (rele-
vant for metabolic disorders and hormone-associated cancers) in a routine setting in males and
females, resembling molecular epidemiology studies: namely, non-fasted and limited control
for other environmental influences. In addition, classical markers to study circadian rhythms
in chronobiology research are measured: cortisol and components of the molecular biological
clock i.e. ‘clock genes’. We determined cortisol levels and clock gene expression levels in blood
throughout the day to study diurnal variation of these classical markers in a routine setting.
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Methods
Study design and ethics statement
Approval for all procedures was obtained from the ethical committee of the Goce Delchev Univer-
sity in Stip, Republic of Macedonia. All participants signed an informed written consent. This was
provided in Macedonian and the translation would be as follows: "I confirm that I am informed
about the goals of the Circadian study and voluntary participate in it. I also confirm that all infor-
mation that I provided with regards to my general health condition and lifestyle is correct”. Sam-
ples of 17 healthy volunteers, 10 women and 7 men were analyzed in this study. Inclusion criteria
were:-age over 21 years old,—apparently healthy without any acute or chronic disease (general
medical examination without laboratory analyses),—not taking any drugs, multivitamins and/or
supplements, -non-smoking,—not more than 1 (for women) or 2 (for men) alcoholic beverages
per day,—no shiftwork and have a normal circadian rhythm (sleeping at nighttime).
The mean age of the males was 24.9 ± 7.2 years and 21.7 ± 0.5 years for the female volunteers.
The mean weight was 84.1 ±13.9 kg for the males and 58.5 ±13.6 kg for the females. For more
participants characteristics and individual data, see S1 Table. The samples were collected around
the clock at four-hour intervals. The first sample was collected at 08:00 AM after overnight fast-
ing. Participants were asked when they slept between the first and last sampling times (8:00–4:00
AM). Total sleep duration between these time-points was 3.4 ± 0.9 hr for males and 3.2 ±1.9 for
females. For individual sleeping duration and timing of sleep episodes, see S1 Table. Volunteers
were asked to consume their meals one hour after sample collection and otherwise continue their
normal daily routines. Meal timing and composition was not further restricted or standardized
and meals were consumed at home. EDTA plasma and buffy coat samples (2.7 mL) and serum
samples (7.5 mL) were collected in a routine clinical chemistry laboratory by venipuncture of the
antecubital vein, using the commercial blood sampling method Sarstedt (Sarstedt AG & Co.,
Nümbrecht, Germany). Individuals were allowed to leave the laboratory after sample collection
and thus were required to wake up and come to the laboratory for sample collection at night.
Plasma and serum analyses
Two methods were used to determine hormonal and lipid biomarkers, an overview can be
found in S2 Table. Free fatty acids (FFA), high-density lipoprotein (HDL), low-density lipopro-
tein (LDL), triglycerides (TG) and cholesterol (CHOL) were determined with an auto-analyzer
(Unicel DxC 800, Beckman-Coulter, Woerden, the Netherlands), using kits from Beckman-
Coulter. Cortisol (CORT), dehydroepiandrosterone sulfate (DHEAS), estradiol (E2), human
growth hormone (hGH), prolactin (PRL), progesterone (PRG), testosterone (TEST), total triio-
dothyronine (TotT3), thyroid-stimulating hormone (TSH) were determined with an immune-
analyzer (Access-2, Beckman-Coulter) using dedicated kits from Beckman-Coulter. Levels of
adrenocorticotropic hormone (ACTH), follicle stimulating hormone (FSH), and luteinizing
hormone (LH) were determined using commercially available Milliplex Kits (Millipore Corpo-
ration, Billerica, MA, USA). All measurements were performed on the same day. The intra-
assay variation was determined with three quality control samples (8 tests) for markers mea-
sured on the auto-analyzer and with two quality control samples (5 tests) for markers measured
on the immune-analyzer. The CVs of markers measured with the Luminex technique were
obtained from the manufacturer. See S2 Table for all CVs.
Blood RNA analysis
Expression levels of clock genes BMAL1 and PER1 were determined in buffy coats of a subset
of volunteers (n = 6, female), using quantitative reverse transcription polymerase chain
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reaction (RT-PCR). All oligonucleotide primers were obtained from Life Technologies (Bleis-
wijk, The Netherlands). Total RNA was extracted from buffy coats stabilized with Qiazol, using
the miRNeasy Mini Kit (both Qiagen Benelux, Venlo, The Netherlands). cDNA was made
using the high capacity cDNA reverse transcription kit (Applied Biosystems by Life Technolo-
gies, Bleiswijk, The Netherlands). qPCR was performed on the 7500 Fast Realt-Time PCR Sys-
tem (Applied Biosystems by Life Technologies, Bleiswijk, The Netherlands) using Taqman Fast
Universal PCR Master Mix and Taqman Gene Expression assays for BMAL1
(Hs00154147_m1) and PER1 (Hs01092603_m1) all according to protocol of manufacturer
(Applied Biosystems by Life Technologies, Bleiswijk, The Netherlands).
Statistics
To detect all types of diurnal variation, parameters were tested using two types of analyses:
cosine fitting analysis and Repeated Measures ANOVA (RM-ANOVA). Depending on the
shape of the day curves, these analyses can be overlapping and/or complementary. The RM-A-
NOVA detects effects of time, i.e. are the levels of the marker different among time-points. The
cosine analysis enables detection of rhythms that follow a cosine curve, in manner that is occa-
sionally more sensitive than the RM-ANOVA. For the cosine analysis, CircWave Batch v5.0
software (Roelof Hut, www.euclock.org) was used. A closer fit to cosine gives lower p-value,
p< 0.05 is assumed a significant cosine curve fit. Repeated Measures ANOVA (RM-ANOVA)
was performed using GraphPad Prism software version 6.04 for Windows (GraphPad Soft-
ware, San Diego California USA, www.graphpad.com). The Greenhouse-Geisser epsilon indi-
cated that sphericity could not be assumed in most analyses, therefore, Greenhouse- Geisser
correction was applied. For the RM-ANOVA, p< 0.05 was considered statistically significant.
If CircWave analysis, RM-ANOVA, or both indicated that signification variation was present,
we identified the markers as having diurnal variation in our experiment. Gene expression of
PER1 and BMAL1 was given as relative expression compared to the mean.
Considering the known difference in levels of several makers between genders, all statistical
analyses were performed separately for males and females. The aim of this study was to identify
markers with diurnal variation, therefore, differences between males and females were not sta-
tistically tested. For all raw data, see S1 File.
Results
We investigated diurnal variation of a set of markers (relevant for metabolic disorders and hor-
monal cancers) in a routine setting in males and females. To determine the diurnal variation
we performed two analyses: 1) Cosine fitting analysis: using CircWave software we determined
whether the level of the marker follows a cosine rhythm; 2) RM-ANOVA analysis: determine
effects of time of day on parameter levels. If analysis 1, analysis 2 or both indicated that signifi-
cant variation was present we identified the markers as having diurnal variation in our
experiment.
Hormones
Cosine analysis showed that for two of the eleven investigated hormonal markers, a significant
cosine curve fit was present in both genders: thyroid-stimulating hormone (TSH) and total tri-
iodothyronine (totT3) (Fig 1). The levels of TSH are highest during the middle of the night,
where in males (m) the peak is observed slightly earlier (Clock Time (CT) = 01:54, p = 0.001,
amplitude as percentage of the median = 75.89%) compared to females (f) (CT = 03:32,
p = 0.006, amplitude = 74.26%). Levels of totT3 are highest at the beginning of the day (m:
CT = 06:18, p 0.025, amplitude = 10.14%; f: CT = 07:04, p = 0.041, amplitude = 8.08%).
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Fig 1. Levels of TSH, TotT3, PROG, and TEST during the day, measured at four-hour intervals for male (left panels) and female (right panels)
volunteers. Time indicates clock time. Values at 8-hr were double plotted to help visualize daily patterns. Data represent mean ±sd.
doi:10.1371/journal.pone.0135652.g001
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Progesterone (PRG) had a significant cosine curve fit in males, but not in females (m:
CT = 07:52, p = 0.003, amplitude = 117.78%; f: p = 0.870) (Fig 1). For testosterone (TEST), a
trend towards a cosine curve fit was present in males, but not females (m: CT = 07:33,
p = 0.055, amplitude = 38.38%; f: p = 0.282) (Fig 1). For a complete overview of CircWave anal-
yses for all 11 hormonal markers, see Figs 1–3 and S3 Table.
For the two markers with a significant cosine fit in both genders, TSH and TotT3, an effect
of time was observed with RM-ANOVA as well (for statistics see S3 Table), although for TotT3
in females only a trend is observed (p = 0.078). In addition, for four markers where a cosine
curve could not significantly be fitted, a significant effect of time was observed, for TEST,
DHEAS, PRG and prolactin (PRL) (Figs 1 and 2). RM-ANOVA shows that TEST and DHEAS
are present at different levels during the 6 time-points in both genders (TEST: m: p 0.021, f:
p = 0.023; DHEAS: m: p = 0.045, f: p = 0.002). Furthermore, PRL and PRG are significantly dif-
ferent over the time-points in one gender: PRL (m: p = 0.014, f: p = 0.118) and PRG (m:
p = 0.020, f: p = 0.272). For complete overview of the results of the RM-ANOVA on all time-
points, see Figs 1–3 and S3 Table.
Lipids
Five types of lipids were examined; free fatty acids (FFA), triglycerides (TG), total cholesterol
(CHOL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) (Fig 4). Cir-
cWave analysis indicated that FFA levels follow a cosine curve in males (p = 0.012, amplitude
74.91%), but not significantly in females (p = 0.359, amplitude = 80.70%). The levels of FFA
were highest at the beginning of the active period in males (CT = 08:31). A trend towards a
cosine curve fit was observed for TG in females (p = 0.050, amplitude = 50.33%), but not in
males (p = 0.105, amplitude = 70.36%) (Fig 4). Visual inspection of the levels of FFA and TG in
Fig 4 implies that the differences between males and females for these markers is likely related
to the variation observed within the groups, since the highest levels are observed at similar
time-points for both genders. For complete overview of all markers, see Fig 4 and S4 Table.
Despite the limited presence of significant cosine curve fits observed among the different
lipid markers, for several markers RM-ANOVA shows significant effects of time: for CHOL
and LDL in both genders (CHOL: m: p = 0.003, f: p = 0.003; LDL: m: p = 0.002, f: p = 0.006),
for TG in males and a trend was present in females (m: p = 0.048, f: p = 0.063) (S4 Table). The
levels of FFA show a trend towards an effect of time in males (m: p = 0.069, f: p = 0.221). For
HDL, no significant effect was observed in any gender (m: p = 0.110, f: p = 0.213). The highest
level of most lipids including FFA, LDL, and CHOL was observed at the beginning of the active
phase, the highest level of TG in males was observed during the middle of the day (Fig 4).
In summary, for all lipid markers, except HDL significant or trends towards diurnal varia-
tion are observed.
Classical circadian markers
The levels of cortisol were investigated in all participants (n = 17), clock genes PER1 and
BMAL1 were investigated in a subset (n = 6, females) to gain insight in classical circadian
markers in uncontrolled conditions (Fig 5). Cortisol levels show a significant cosine curve fit,
are highest at the beginning of the day (m: CT = 07:47; f: CT = 07:29), and the rhythm has a rel-
ative large amplitude (m: p< 0.0005, amplitude = 129.11%; f: p< 0.0005, amplitude = 161.63%)
(Fig 5, upper panels). The levels of PER1 and BMAL1mRNA show a significant cosine curve fit
as well (PER1 p = 0.002, amplitude = 80.15%; BMAL1 p = 0.035, amplitude = 35.55%). Levels
of PER1 were highest during the morning (CT = 8:07), while levels of BMAL1 were highest dur-
ing the afternoon (CT = 14:12). For complete overview of statistics see S5 Table.
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Fig 2. Levels of DHES, PRL, LH, and FSH during the day, measured at four-hour intervals for male (left panels) and female (right panels)
volunteers. Time indicates clock time. Values at 8-hr were double plotted to help visualize daily patterns. Data represent mean ±sd.
doi:10.1371/journal.pone.0135652.g002
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Discussion
The aim of the present study was to investigate diurnal variation in a set of hormones, meta-
bolic markers, and classical circadian markers in serum, plasma and peripheral blood
Fig 3. Levels of ACTH, hGH, and E2 during the day, measured at four-hour intervals for male (left panels) and female (right panels) volunteers.
Time indicates clock time. Values at 8-hr were double plotted to help visualize daily patterns. Data represent mean ± sd.
doi:10.1371/journal.pone.0135652.g003
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Fig 4. Levels of different lipids during the day, measured at four-hour intervals for male (left panels) and female (right panels) volunteers. Time
indicates clock time. Values at 8-hr were double plotted to help visualize daily patterns. Data represent mean ±sd.
doi:10.1371/journal.pone.0135652.g004
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mononuclear cells (PBMCs), in a routine non-fasted molecular epidemiology-like setting, with
no restrictions on sleep or diet.
Hormones
Markers without diurnal variation. For markers without diurnal variation, taking the
time-point of sampling into account is not required. This study observed no diurnal variation
or trends towards diurnal variation in any gender in four of the eleven hormonal markers
investigated, ACTH, hGH, E2, and FSH. Previous published studies performed in a different
type of setting than the present study, namely a controlled (laboratory) settings do show diur-
nal variation in ACTH levels in males, with the highest level being observed at CT 4.00 h [16]
or CT 7.00 h [22], whereas no diurnal was observed in females [22]. Interestingly, in the pres-
ent study, levels were also highest at CT 4.00, indicating similar patterns. However, in our
study larger amount of variation is expected than a controlled laboratory setting potentially
causing the diurnal variation of ACTH undetectable within the inter-individual variations.
Fig 5. Around the clock levels for classical circadianmarkers cortisol, PER1 and BMAL1. Upper panels show cortisol levels in male (left panels) and
female (right panels) volunteers, determined in serum. mRNA expression of BMAL1 and PER1 in buffy coats are depicted in the lower panels (females
subset n = 6). All were measured at 4 hour intervals, where time indicates clock time. Values at 8-hr were double plotted to help visualize daily patterns. Data
represent mean ±sd.
doi:10.1371/journal.pone.0135652.g005
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Since during day time-points, when sampling is usually performed in a cohort study, variation
in ACTH levels is minimal. Thus, diurnal variation seems not to be a major issue for ACTH in
a molecular epidemiology setting. However, considering the previous studies on ACTH and
that in a large cohort setting power will be increased, diurnal variation might become larger
than the inter-individual variation and caution is required. In addition, if subjects are investi-
gated which possibly have a circadian disruption (e.g. night shift workers), variation in levels of
the markers during night time-points should be taken into account as well (see recommenda-
tions section for suggestions).
For hGH, former reports in controlled settings have shown diurnal variation in males [22,
23]. However, it is important to note that it is known that hGH is released in pulses with levels
varying up to 4 times [24]. Hence, in the present study with sampling intervals of 4 hours these
pulse releases might interfere with the detection of diurnal variation. Indeed, in the present
study at several time-points large variations in the levels of hGH are observed, particularly in
males. This indicates that hGH is a difficult marker to measure in a non-time-controlled cohort
setting, since possible differences are easily masked by the large amount of variation present for
this marker.
For estradiol, the absence of diurnal variation in the present study is in line with previous
studies that reported the absence of diurnal variation in females [25, 26], although diurnal vari-
ation is observed in estradiol levels in elderly females (mean age 77 years) [22]. Together, these
data indicate that in a cohort study with non-elderly adults, diurnal variation of estradiol is not
an issue.
For FSH, conflicting data have been published previously. In females, the absence of a diur-
nal variation was reported in studies using (mildly) controlled settings [15, 22], while a third
study reported diurnal variation in females during different phases of the menstrual cycle, with
the highest levels of FSH being observed during the afternoon [26]. For males, conflicting
results have been reported as well: a study by Spratt et al. showing the absence of diurnal varia-
tion in males [27], while Nicolau et al., reported the presence of a diurnal variation in elderly
males [22]. Possibly, age has a role in the diurnal variation of FSH. However, the present study
indicates that in a routine setting, time of day is not a major source of variation for FSH levels.
Markers with diurnal variation. For eight of the twelve investigated hormonal markers,
diurnal variation was observed in at least one gender. Markers with the most robust diurnal
variation in both genders were TSH and T3. This is in line with previous findings for these
markers [15, 22, 23, 28]. For DHEAS, a previous study reported circadian rhythmicity in males
and females [22], however, in the present study the rhythm of DHEAS could not be fitted to a
cosine curve. The levels of DHEAS differed among the time-points and the pattern of expres-
sion (e.g. highest levels in the afternoon) is comparable to the previously published results, con-
firming diurnal variation of DHEAS.
For testosterone, diurnal variation was not robust, but significant changes were observed
when the time-points were compared in both genders. Diurnal variation in testosterone is in
line with previous findings [22, 25, 27, 29–31]. The study by Spratt et al. showed that the
robustness of the diurnal variation of testosterone was largely dependent on the frequency of
sampling.
For several of the other markers, the robustness of diurnal variation varied among genders.
Diurnal variation was often more pronounced in males. Since in the present study menstrual
period was not assessed, nor was the use of contraceptives, this might explain the less robust
results in females. For example, progesterone showed diurnal variation in males, but not
females. For females, it has been shown that the rhythmicity of progesterone varies with the
menstrual period, including the timing of the highest levels [22, 32, 33]. Interestingly, 5 females
show high progesterone levels, which are indicative of the lutheal phase. Of these females, two
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show a significant or trend (p-value between 0.05 and 0.1) towards an individual cosine curve
fit (#6: p = 0.0059 and #7: p = 0.05222). These results suggest that indeed variation in menstrual
period, and possibly contraceptives use, interfere with measurements of progesterone in a
cohort setting.
For the final two markers, LH and PRL, only mild amounts of diurnal variation were
observed. For LH previous studies in females have shown that rhythmicity is dependent on the
menstrual cycle and that peak timing differs among women [15, 26, 33], which likely explains
the results of the present study. For prolactin, in the present study only a trend towards a cosine
curve fit was observed in females and effects of time (by RM-ANOVA) in males. This is in line
with previous studies that have shown diurnal variation of prolactin in females in controlled
settings [32, 34], and higher levels of prolactin during the night in males [35]. Together, these
results indicate that for prolactin time of day should be taken into account (see recommenda-
tions section for suggestions).
Lipids
Of the 5 lipid markers, only HDL showed no diurnal variation (no cosine curve fit and no effect
of time by RM-ANOVA). Previously, it has been shown that a large subset of lipids shows diur-
nal variation for examples see references: [36, 37], for review see reference: [38], however, the
rhythmicity of these markers is highly variable among individuals [37]. Furthermore, it is
known that many lipids are directly regulated by the endogenous circadian clock [20, 21, 38],
lipid metabolism is related to sleep [19, 39], and that levels of FFA, TG and LDL are dependent
on meal-timing [40, 41] The results of the present study, diurnal variation in LDL, TG, FFA
and total cholesterol are thus in line with previous findings. These results show that for these
markers time of day needs to be taken into account (see recommendations section below for
suggestions). Previously, diurnal variation has been observed for HDL in a controlled setting
[36], however, our study indicates that this variation does not exceed the inter-individual varia-
tion in a routine setting.
Classical circadian markers
In chronobiology research, several markers are often used to study circadian rhythm. Hence,
these can be named as ‘classical circadian markers’. One of these markers is cortisol, which is
often used to study circadian rhythm in humans. In addition, components of the molecular
biological clock can be used to study circadian rhythm, i.e. ‘clock genes’. Since these genes are
part of the core clock mechanism in cells, their rhythm reflects the circadian rhythm in these
cells. We show that the ‘classical circadian markers’ investigated in this study (cortisol and the
clock genes PER1 and BMAL1) have a robust cosine curve fit in our study population, which
resembles a routine non-fasted molecular epidemiology setting. Our findings for cortisol
(rhythmic expression with high levels during the early morning), are in line with previous liter-
ature. Multiple studies, in a range of different settings, have reported similar findings (for
review see reference [12], for examples see references [42–44]).
In our study PER1 expression fits to a cosine curve with the highest levels in the morning,
which is also consistent with previous studies. For example, James et al. observed rhythmic
PER1 expression with peak levels on average 2:36 h after waking (±1:47 h) in PBMCs [18],
Kusanagi et al. observed rhythmic PER1expression with peak expression on average at 7:42 h in
PMBCs [42], and Takimoto et al. reported peak levels at 06:00 h in whole blood cells [43]. For
BMAL1, previous studies have indicated that rhythmicity of BMAL1 gene expression in
PBMCs is highly variable amongst individuals [18, 44]. For example, BMAL1 expression has
been reported to be high during the middle of the day (comparable to our study) [18, 44],
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during the night [43], during the evening [44], or not being rhythmic [42]. Teboul et al. sug-
gested that this variation might be related to chronotype, since in their study two groups of
individuals could be distinguished: peak expression of BMAL1 during the middle of the day
(12:30 hr) or during the evening (21:45 hr).
Together, our results shows that thediurnal variation, including the acrophase of the fitted
cosine curves, of several classical markers in our study is comparable to previous studies using
(mildly) controlled settings [18, 42–44].
Concluding remarks and reccomendations
The present study showed that markers for which diurnal variation (circadian rhythms and/or
time-of-day-effects) is not an issue in a routine setting are ACTH, FSH, E2 and HDL. For all
other tested markers diurnal variation was observed, which exceeded the inter-individual varia-
tion in a routine setting. It is important to note that we tested this in a small test group
(n = 17). In a large cohort with numerous subjects, levels of inter-individual variation might
decrease due to larger sample sizes, making the contribution of diurnal variation relatively
larger. Hence, for some of the markers without detectable diurnal variation in the present
study, diurnal variation might play a role in larger studies. Nevertheless, our study provides an
indication for which markers diurnal variation needs to be taken into account in a routine
setting.
Taking diurnal variation into account can be done in several ways depending on the study
design and marker characteristics (such as dependent on food intake, sleep/wake cycle etc.).
For example, measurements can be taken at a single time-point or if sampling at a single time-
points is not possible, registration of sampling time and their relevant time-points (e.g. timing
of food intake) is an alternative method to take into account diurnal variation. Apart from a
research setting, several of the markers in our study are measured in a clinical setting as well. In
general, a substantial amount of variance is incorporated in reference levels for diagnostic pur-
poses. However, for biomarkers with large diurnal variation it might be beneficial to take multi-
ple samples during the day or define reference levels that take into account time-of-day.
Our finding that most markers tested show diurnal variation is in line with recent studies
showing that many genes are regulated by the circadian clock. For example, a recent study has
shown that 43% of the protein coding genes shows diurnal variation in at least one organ in
mice [45], as a consequence one could expect diurnal variation in many serum or plasma pro-
tein levels as well. This large set of markers with diurnal variation indicates the need for investi-
gating diurnal variation before setting up studies measuring markers in routine and controlled
settings, since time- of- day likely matters for many more markers than the ones investigated in
the present study.
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